Related Experiment Video
Updated: May 28, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
A tumor-secreted protein utilizes glucagon release to cause host wasting
Guangming Ding1,2, Yingge Li1,2, Chen Cheng1,2
1Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, Hubei, China.
Abstract:
Tumor‒host interaction plays a critical role in malignant tumor-induced organ wasting across multiple species. Despite known regulation of regional wasting of individual peripheral organs by tumors, whether and how tumors utilize critical host catabolic hormone(s) to simultaneously induce systemic host wasting, is largely unknown. Using the conserved yki3SA-tumor model in Drosophila, we discovered that tumors increase the production of adipokinetic hormone (Akh), a glucagon-like catabolic hormone, to cause systemic host wasting, including muscle dysfunction, lipid loss, hyperglycemia, and ovary atrophy. We next integrated RNAi screening and Gal4-LexA dual expression system to show that yki3SA-gut tumors secrete Pvf1 to remotely activate its receptor Pvr in Akh-producing cells (APCs), ultimately promoting Akh production. The underlying molecular mechanisms involved the Pvf1-Pvr axis that triggers Mmp2-dependent ECM remodeling of APCs and enhances innervation from the excitatory cholinergic neurons. Interestingly, we also confirmed the similar mechanisms governing tumor-induced glucagon release and organ wasting in mammals. Blockade of either glucagon or PDGFR (homolog of Pvr) action efficiently ameliorated organ wasting in the presence of malignant tumors. Therefore, our results demonstrate that tumors remotely promote neural-associated Akh/glucagon production via Pvf1-Pvr axis to cause systemic host wasting.
Insights
Malignant tumors promote systemic organ wasting by increasing adipokinetic hormone (Akh) or glucagon production. This occurs via a Pvf1-Pvr signaling pathway that enhances neural activity in hormone-producing cells.
Area of Science:
- Molecular Biology
- Endocrinology
- Cancer Biology
Background:
- Tumor-host interactions are crucial in cancer progression and cachexia.
- The mechanisms by which tumors induce systemic organ wasting are not fully understood.
- Adipokinetic hormone (Akh) is a catabolic hormone with known roles in energy metabolism.
Purpose of the Study:
- To investigate how tumors induce systemic host wasting.
- To identify the key hormones and signaling pathways involved in tumor-induced cachexia.
- To explore potential therapeutic targets for mitigating organ wasting in cancer patients.
Main Methods:
- Utilized a conserved yki3SA-tumor model in Drosophila.
- Employed RNAi screening and Gal4-LexA dual expression system.
- Investigated the Pvf1-Pvr signaling axis and its downstream effects on Akh production and innervation.
Main Results:
- yki3SA-gut tumors increase Akh production, leading to systemic wasting (muscle dysfunction, lipid loss, hyperglycemia, ovary atrophy).
- Tumors secrete Pvf1, which activates Pvr on Akh-producing cells (APCs), promoting Akh production via Mmp2-dependent ECM remodeling and enhanced cholinergic innervation.
- Similar mechanisms involving glucagon and PDGFR (Pvr homolog) were confirmed in mammals, with blockade ameliorating organ wasting.
Conclusions:
- Tumors remotely induce systemic host wasting by promoting neural-associated Akh/glucagon production.
- The Pvf1-Pvr signaling axis is a key mediator of tumor-induced cachexia.
- Targeting glucagon or PDGFR signaling may offer therapeutic strategies against cancer-related organ wasting.
More Related Videos
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
Related Concept Videos
Hypoglycemia and Glucagon
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Regulation of Food Intake
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...